78 results on '"Blok, Leen J"'
Search Results
2. Supplementary Data from Progesterone Inhibition of Wnt/β-Catenin Signaling in Normal Endometrium and Endometrial Cancer
3. Supplementary Data from Progesterone Inhibition of Wnt/β-Catenin Signaling in Normal Endometrium and Endometrial Cancer
4. Supplementary Figure S1 from IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
5. Supplementary Figure S2 from IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
6. Supplementary Table S2 from IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
7. Supplementary Figure S3 from IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
8. Supplementary Figure Legends from IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
9. Supplementary Table S1 from IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
10. Supplementary Figure S2 from IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
11. Supplementary Figure Legends from IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
12. Supplementary Table S1 from IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
13. Supplementary Figure S3 from IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
14. Supplementary Table S2 from IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
15. Data from IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
16. Data from IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
17. Supplementary Methods from IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
18. Supplementary Figure S1 from IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
19. Supplementary Methods from IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
20. RNA Expression Profiling
21. Isolation of Differentially Expressed cDNAs from Prostate Cancer Cell Lines Using Differential Display PCR: Identification of an Androgen-Regulated Gene
22. IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
23. Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors
24. A mouse model for endometrioid ovarian cancer arising from the distal oviduct
25. Alterations in Wnt-β -catenin and Pten signalling play distinct roles in endometrial cancer initiation and progression
26. Identification of Quiescent, Stem-Like Cells in the Distal Female Reproductive Tract
27. Interaction between sex hormones and WNT/β-catenin signal transduction in endometrial physiology and disease
28. An Autoimmune Phenotype in Vulvar Lichen Sclerosus and Lichen Planus: A Th1 Response and High Levels of MicroRNA-155
29. Progesterone Inhibits Epithelial-to-Mesenchymal Transition in Endometrial Cancer
30. AMG 479, a Novel IGF-1-R Antibody, Inhibits Endometrial Cancer Cell Proliferation Through Disruption of the PI3K/Akt and MAPK Pathways
31. Different DNA damage and cell cycle checkpoint control in low- and high-risk human papillomavirus infections of the vulva
32. Loss of APC function in mesenchymal cells surrounding the Müllerian duct leads to myometrial defects in adult mice
33. Treatment of vulvar intraepithelial neoplasia with topical imiquimod: Seven years median follow-up of a randomized clinical trial
34. Progesterone Receptor-B Induction of BIRC3 Protects Endometrial Cancer Cells from AP1-59-Mediated Apoptosis
35. Wnt/Β-Catenin and Sex Hormone Signaling In Endometrial Homeostasis and Cancer
36. Nonsteroidal anti‐inflammatory drugs do not interfere with imiquimod treatment for usual type vulvar intraepithelial neoplasia
37. Premalignant epithelial disorders of the vulva: squamous vulvar intraepithelial neoplasia, vulvar Paget's disease and melanoma in situ
38. Abstract 4208: Constitutive activation of Wnt/beta-catenin signaling induces uterine developmental defects
39. Microsomal epoxide hydrolase expression in the endometrial uterine corpus is regulated by progesterone during the menstrual cycle
40. Imiquimod‐induced clearance of HPV is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia
41. Progesterone Inhibition of Wnt/β-Catenin Signaling in Normal Endometrium and Endometrial Cancer
42. Progesterone Receptor Membrane Component 1 Promotes Endometrial and Breast Cancer Cell Viability in Response to Chemotherapy In Vitro and In Vivo.
43. Cables 1 Interacts with p300 to Regulate Progesterone-Induced Endometrial Glycodelin Expression.
44. Genome-wide pathway analysis of folate-responsive genes to unravel the pathogenesis of orofacial clefting in man
45. Reduced local immunity in HPV-related VIN: Expression of chemokines and involvement of immunocompetent cells
46. Signaling by estrogens and tamoxifen in the human endometrium
47. Progesterone-Mediated Regulation of Catechol-O-Methyl Transferase Expression in Endometrial Cancer Cells
48. The Regulation and Function of the Forkhead Transcription Factor, Forkhead Box O1, Is Dependent on the Progesterone Receptor in Endometrial Carcinoma
49. Genomic and Nongenomic Effects of Estrogen Signaling in Human Endometrial Cells: Involvement of the Growth Factor Receptor Signaling Downstream AKT Pathway
50. Levels of Tibolone and Estradiol and their Nonsulfated and Sulfated Metabolites in Serum, Myometrium, and Vagina of Postmenopausal Women Following Treatment for 21 Days With Tibolone, Estradiol, or Estradiol Plus Medroxyprogestrone Acetate
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.